Thomas Leggett
Chief Financial Officer · 2 filings · Latest: Mar 17, 2026
Stoke Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
STOK | Thomas Leggett | Chief Financial Officer | Mar 18, 2026 | Sale | $31.34 | 2,382 | $74.7K | 10,172 | |
STOK | Thomas Leggett | Chief Financial Officer | Mar 17, 2026 | Sale | $33.01 | 2,196 | $72.5K | 12,554 | |
STOK | Thomas Leggett | Chief Financial Officer | Mar 15, 2026 | Option Exercise | $0.00 | 14,750 | — | 14,750 |